Abstract
Relaxation of vascular smooth muscle and prevention of blood coagulation are mediated by ligand-induced activation of the human prostacyclin (hIP) receptor, a seven-transmembrane-domain G-protein-coupled receptor (GPCR). In this study, we elucidate the molecular requirements for receptor activation within the region of the ligand-binding pocket, identifying transmembrane residues affecting potency. Eleven of 30 mutated residues in the region of the ligand-binding domain exhibited defective activation (decreased potency). These critical residues localized to four distinct clusters (analysis via a rhodopsin-based human prostacyclin receptor homology model). Residues Y75(2.65) (TMII), F95(3.28) (TMIII), and R279(7.40) (TMVII) comprised the immediate binding-pocket cluster and were shown to be essential for proper receptor activation, compared to equivalent expression levels of the wild-type hIP (WT EC(50) = 1.2 +/- 0.1 nM; Y75(2.65)A EC(50) = 347.3 +/- 62.8 nM, p < 0.001; F95(3.28)A EC(50) = 8.0 +/- 0.6 nM, p < 0.001; R279(7.40)A EC(50) = 130 +/- 63.0 nM, p < 0.001). Residues S20(1.39) (TMI), F24(1.43) (TMI), and F72(2.62) (TMII) were localized to a cluster involving P17(1.36), a critical residue thought to facilitate transmembran...Continue Reading
References
Jul 14, 1995·The Journal of Biological Chemistry·S C SealfonH Weinstein
Jul 28, 1995·The Journal of Biological Chemistry·L F KolakowskiN P Gerard
Oct 3, 1999·The Journal of Biological Chemistry·C A FlanaganS C Sealfon
Apr 4, 2000·FEBS Letters·S MiuraS S Karnik
Apr 15, 2000·The Journal of Biological Chemistry·D J WaughD M Perez
Sep 5, 2001·The Journal of Biological Chemistry·R S OstromP A Insel
Feb 21, 2002·The Journal of Biological Chemistry·Jeremiah StithamJohn Hwa
May 23, 2002·The Journal of Biological Chemistry·Sinead M Miggin, B Therese Kinsella
Nov 26, 2002·The Journal of Biological Chemistry·Jeremiah StithamJohn Hwa
Dec 6, 2003·Pharmacological Reviews·Richard R NeubigUNKNOWN International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification
Citations
Apr 14, 2009·Current Atherosclerosis Reports·Scott GleimJohn Hwa
Aug 19, 2007·Journal of the American Chemical Society·Youyong LiAbdelazize Laoui
Nov 7, 2008·Nature·Stacey K OgdenDavid J Robbins
Dec 30, 2010·The Journal of Biological Chemistry·Jeremiah StithamJohn Hwa
Aug 3, 2010·The Journal of Biological Chemistry·Xavier IturriozCatherine Llorens-Cortes
Mar 17, 2007·American Journal of Respiratory Cell and Molecular Biology·Koichiro KamioStephen I Rennard
Jun 3, 2014·PloS One·Anke BillPaul J Groot-Kormelink
Mar 24, 2009·Journal of Molecular and Cellular Cardiology·Zsolt KaszaKathleen A Martin
Aug 21, 2007·British Journal of Pharmacology·J StithamJ Hwa
Nov 1, 2007·Proteins·Chris de GraafDidier Rognan
Dec 14, 2006·Prostaglandins & Other Lipid Mediators·Kristina M FetalveroJohn Hwa
Dec 14, 2006·Prostaglandins & Other Lipid Mediators·Jeremiah StithamJohn Hwa
May 29, 2016·American Journal of Physiology. Heart and Circulatory Physiology·Yan Cheng NgSangho Kim
Jan 10, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Kristina M FetalveroKathleen A Martin
Oct 4, 2006·The Journal of Biological Chemistry·Jeremiah StithamJohn Hwa
Feb 23, 2011·The Open Cardiovascular Medicine Journal·Aamer SandooGeorge D Kitas
Oct 27, 2015·Clinical Pharmacology and Therapeutics·M Holinstat, P F Bray
Feb 13, 2007·The Journal of Biological Chemistry·Melinda HauserJeffrey M Becker
Dec 22, 2017·Journal of Chemical Theory and Computation·Vishnu ShankarFan Liu